KLRB1 and breast cancer: We next verified the favorable prognostic value of CD161 in BC by PrognoScan database with GEO data (GSE7378, DFS, HR = 0.21, p < 0.001; GSE1456, DSS, HR = 0.61, p = 0.032) (Figures 2E,F).